Clinical Trial Update: Preoperative Lanreotide Treatment in Acromegalic Patients With Macroadenomas [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 trial evaluating preoperative lanreotide for patients with acromegaly and macroadenomas.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly

Drugs mentioned

• Somatuline (lanreotide) (lanreotide)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Acromegaly | Phase 2 | Status: UNKNOWN